d-alpha tocopherol has been researched along with saquinavir in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Griffin, BT; O'Driscoll, CM | 1 |
| Chao, Y; Grigorian, A; Hurford, R; Langford, TD; Patrick, C | 1 |
| Geldenhuys, WJ; Lockman, PR; Manda, VK; Mittapalli, RK | 1 |
| Davis, BM; Davis, S; O'Shea, P; Petrov, PG; Richens, JL; Vere, KA; Winlove, CP | 1 |
1 review(s) available for d-alpha tocopherol and saquinavir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for d-alpha tocopherol and saquinavir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
Topics: Anesthesia; Animals; Biological Availability; Biological Transport; Excipients; HIV Protease Inhibitors; Intestinal Absorption; Intestinal Mucosa; Lymph; Male; Micelles; Oleic Acid; Polyethylene Glycols; Rats; Rats, Wistar; Saquinavir; Succinates; Triglycerides; Vitamin E | 2006 |
Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir.
Topics: Aspartic Acid Endopeptidases; Cell Survival; Cells, Cultured; Cerebral Arteries; Cerebral Veins; Endothelial Cells; Frontal Lobe; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Notch1; Receptor, Notch4; Receptors, Notch; Repressor Proteins; Ritonavir; Saquinavir; Vitamin E | 2008 |
Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Interactions; Endothelial Cells; HIV Protease Inhibitors; Male; Membrane Proteins; Nicotine; Oxidative Stress; Phosphoproteins; Proto-Oncogene Proteins; Rats; Rats, Inbred F344; Reactive Oxygen Species; Receptor, Notch4; Receptors, Notch; Saquinavir; Smoking; Vitamin E; Zonula Occludens-1 Protein | 2010 |
α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein.
Topics: alpha-Tocopherol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Fluoresceins; Fluorescent Dyes; Humans; Jurkat Cells; Ketocholesterols; Ligands; Membrane Potentials; Models, Molecular; Molecular Conformation; Phosphatidylethanolamines; Protein Binding; Pyridinium Compounds; Saquinavir; Unilamellar Liposomes | 2015 |